Aristolochic Acid and ‘Chinese Herbs Nephropathy’
暂无分享,去创建一个
[1] U. Mengs,et al. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology , 2005, Archives of Toxicology.
[2] U. Mengs,et al. Acute toxicity of aristolochic acid in rodents , 1987, Archives of Toxicology.
[3] J. Mehes,et al. Selektive chemische Ausschaltung der Harnkanälchen I. Ordnung bei Kaninchen , 1958, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[4] U. Mengs,et al. Tumour induction in mice following exposure to aristolochic acid , 2004, Archives of Toxicology.
[5] F. Würgler,et al. Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity tests , 2004, Archives of Toxicology.
[6] M. Jadoul,et al. The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] V. Arlt,et al. Is aristolochic acid a risk factor for Balkan endemic nephropathy‐associated urothelial cancer? , 2002, International journal of cancer.
[8] V. Arlt,et al. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. , 2002, Mutagenesis.
[9] C. Harris,et al. The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.
[10] J. Cosyns. When is "aristolochic acid nephropathy" more accurate than "Chinese herbs nephropathy"? , 2002, Kidney international.
[11] Yuh-Feng Lin,et al. Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] P. Vereerstraeten,et al. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Graham M Lord,et al. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] I. Salmon,et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. , 2002, Journal of the American Society of Nephrology : JASN.
[15] Chung-hsin Chang,et al. Rapidly Progressive Interstitial Renal Fibrosis Associated with Chinese Herbal Medications , 2001, American Journal of Nephrology.
[16] Graham M Lord,et al. Urothelial malignant disease and Chinese herbal nephropathy , 2001, The Lancet.
[17] M. Jadoul,et al. Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"? , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] M. Gregory,et al. Is "Chinese herbs nephropathy" a prejudicial term? , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] H. Chen,et al. Time to abandon the term "Chinese herbs nephropathy". , 2001, Kidney international.
[20] V. Arlt,et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. , 2001, Kidney international.
[21] Y. Yu,et al. [An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy]. , 2001, Zhonghua nei ke za zhi.
[22] N. Kamatani,et al. Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome. , 2001, Internal medicine.
[23] F. Zheng,et al. [Establishment of model of aristolochic acid-induced chronic renal interstitial fibrosis in rats]. , 2001, Zhonghua yi xue za zhi.
[24] W. Chen,et al. [The clinical and pathological manifestations of aristolochic acid nephropathy--the report of 58 cases]. , 2001, Zhonghua yi xue za zhi.
[25] P. Hainaut,et al. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe , 2001, British Journal of Cancer.
[26] V. Arlt,et al. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. , 2001, Mutation research.
[27] Y. Guiot,et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? , 2001, Kidney international.
[28] T. Kuwahara,et al. Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium? , 2001, Internal medicine.
[29] B. Krumme,et al. Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] V. Arlt,et al. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR. , 2001, Carcinogenesis.
[31] P. Vereerstraeten,et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) , 2000, The New England journal of medicine.
[32] D A Kessler,et al. Cancer and herbs. , 2000, The New England journal of medicine.
[33] A. Sugawara,et al. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? , 2000, Clinical nephrology.
[34] J. Vanherweghem. Nephropathy and herbal medicine. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] H. Hsu,et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] V. Arlt,et al. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. , 2000, Carcinogenesis.
[37] Graham M Lord,et al. Nephropathy caused by Chinese herbs in the UK , 1999, The Lancet.
[38] E. Frei,et al. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. , 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[39] J. Squifflet,et al. Urothelial lesions in Chinese-herb nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] Y. Ubara,et al. A case of Chinese herbs–induced renal interstitial fibrosis associated with fibrosis of salivary glands , 1999 .
[41] M. D. de Broe,et al. Role of serotonin in the development of Chinese herbs nephropathy? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[42] R. Goebbels,et al. Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats , 1998, Archives of Toxicology.
[43] C. V. Strihou,et al. Chinese herbs nephropathy or the evils of nature. , 1998 .
[44] A. Yang,et al. Interstitial renal fibrosis in a young woman: association with a Chinese preparation given for irregular menses. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[45] L. Dworkin,et al. Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] V. Stefanović. Balkan endemic nephropathy: a need for novel aetiological approaches. , 1998, QJM : monthly journal of the Association of Physicians.
[47] J. Cuykens,et al. Valvular heart disease and Chinese-herb nephropathy , 1998, The Lancet.
[48] C. D. Strihou. [Soft medicine, innocuous medicine?] , 1998 .
[49] M. McIntyre. Chinese herbs: risk, side effects, and poisoning: the case for objective reporting and analysis reveals serious misrepresentation. , 1998, Journal of alternative and complementary medicine.
[50] J. Vanherweghem,et al. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) , 1998, Journal of alternative and complementary medicine.
[51] E. Jones,et al. [End-stage renal insufficiency associated with Chinese herbal consumption in France]. , 1998, Nephrologie.
[52] A. Singer,et al. Can physics and physical chemistry explain the workings of homeopathy? A clinician's view. , 1998, Journal of alternative and complementary medicine.
[53] A. Sugawara,et al. [Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function]. , 1997, Nihon Jinzo Gakkai shi.
[54] M. Stiborová,et al. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. , 1997, Carcinogenesis.
[55] A. Sugawara,et al. [Chinese herbs nephropathy in the Kansai area: a warning report]. , 1997, Nihon Jinzo Gakkai shi.
[56] E. Frei,et al. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases. , 1997, Carcinogenesis.
[57] R. Hänsel,et al. Adverse Effects of Herbal Drugs , 1993, Adverse Effects of Herbal Drugs.
[58] M. Jadoul,et al. Chinese herbs nephropathy presentation, natural history and fate after transplantation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[59] R. Lauwerys,et al. Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria. , 1997, Kidney international.
[60] M. D. de Broe,et al. Combination analgesic involvement in the pathogenesis of analgesic nephropathy: the European perspective. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[61] G. Duggin. Combination analgesic-induced kidney disease: the Australian experience. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[62] J. M. Peña,et al. Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[63] S. Klahr,et al. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. , 1996, Kidney international. Supplement.
[64] C. van Ypersele de Strihou,et al. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. , 1996, Cancer research.
[65] D. Abramowicz,et al. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[66] T. Broschard,et al. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha. , 1995, Cancer letters.
[67] M. Jadoul,et al. Low molecular weight proteinuria in Chinese herbs nephropathy. , 1995, Kidney international.
[68] J L Vanherweghem,et al. Chinese herbs nephropathy and renal pelvic carcinoma. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[69] C. van Ypersele de Strihou,et al. The tragic paradigm of Chinese herbs nephropathy. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[70] O. Rascol,et al. [Nephropathy associated with Chinese herbal drugs. 2 cases]. , 1994, Presse medicale.
[71] C. W. von der Lieth,et al. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid. , 1994, Carcinogenesis.
[72] J L Vanherweghem,et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[73] J. Squifflet,et al. Urothelial malignancy in nephropathy due to Chinese herbs , 1994, The Lancet.
[74] E. Frei,et al. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures. , 1994, Carcinogenesis.
[75] C van Ypersele de Strihou,et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? , 1994, Kidney international.
[76] P. But,et al. Identification of aristolochic acid in Chinese herbs , 1994, The Lancet.
[77] O. Rascol,et al. NEOPHROPATHIE ASSOCIEE A DES HERBES CHINOISES : 2 CAS , 1994 .
[78] L. Yong. Renal pathology : with clinical and functional correlations , 1993 .
[79] J. Brostoff,et al. Need for correct identification of herbs in herbal poisoning , 1993, The Lancet.
[80] M. Jadoul,et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.
[81] M. Wiessler,et al. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. , 1993, IARC scientific publications.
[82] D. CvorisCec,et al. Relationship of anemia to Balkan endemic nephropathy. , 1991, Kidney international. Supplement.
[83] J. Hranisavljević,et al. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. II. Protein excretion. , 1991, Kidney international. Supplement.
[84] V. Stefanović,et al. Urinary tract tumors and Balkan nephropathy in the South Morava River basin. , 1991, Kidney international. Supplement.
[85] A. Vizjak,et al. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. III. Light and electron microscopic studies. , 1991, Kidney international. Supplement.
[86] D. Ferluga. XIII European Congress of Pathology Sept. 1–6, 1991, Ljubljana, Yugoslavia , 1991 .
[87] Wolf Cr. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals. , 1991 .
[88] V. Stefanović,et al. Balkan nephropathy. Kidney disease beyond the Balkans? , 1991, American journal of nephrology.
[89] J. M. Zhu,et al. Effect of aluminum on bone matrix inductive properties. , 1990, Kidney international.
[90] C. Bartram,et al. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. , 1990, Cancer research.
[91] M. Wiessler,et al. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. , 1990, Carcinogenesis.
[92] K. Oldhafer,et al. Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[93] H. J. Roth,et al. Studies on the metabolism of aristolochic acids I and II. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.
[94] M. McCredie,et al. Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer. , 1986, Kidney international.
[95] S. Olsen. [Histopathology of drug and toxin induced kidney lesions]. , 1986, Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie.
[96] G. Zbinden,et al. Aristolochic acid induces 6-thioguanine-resistant mutants in an extrahepatic tissue in rats after oral application. , 1985, Mutation research.
[97] B. Pool,et al. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium. , 1984, Cancer letters.
[98] W. Göggelmann,et al. Aristolochic acid is a direct mutagen in Salmonella typhimurium. , 1982, Mutation research.
[99] P. Hall. Endemic Balkan Nephropathy , 1982 .
[100] S. Batsford,et al. [Double blind study of the influence of aristolochic acid on granulocyte phagocytic activity]. , 1982, Arzneimittel-Forschung.
[101] S. Johansson,et al. Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. , 1981, Kidney international.
[102] I. Bjerkfis. Light and Electron Microscopic Studies , 1977 .
[103] Rücker Vg,et al. [Aristolochic acids from Aristolochia manshuriensis (author's transl)]. , 1975 .
[104] J. Möse,et al. [Further studies on aristolochic acid. I]. , 1974, Arzneimittel-Forschung.
[105] M. Pailer,et al. Die Konstitution der Aristolochiasäure-IV , 1967 .
[106] M. Pailer,et al. Die Konstitution der Aristolochiasäuren III und IIIa , 1966 .
[107] R. Griggs,et al. INVESTIGATION OF CHRONIC ENDEMIC NEPHROPATHY IN YUGOSLAVIA. II. RENAL PATHOLOGY. , 1965, The American journal of medicine.
[108] M. Pailer,et al. Über die Isolierung und Charakterisierung von vier neuen Aristolochiasäuren (aus Aristolochia clematitis L.) , 1965 .
[109] H. Brodovsky,et al. ARISTOLOCHIC ACID (NSC-50413): PHASE I CLINICAL STUDY. , 1964, Cancer chemotherapy reports.
[110] S. M. Kupchan,et al. TUMOR INHIBITORS. I. ARISTOLOCHIC ACID, THE ACTIVE PRINCIPLE OF ARISTOLOCHIA INDICA. , 1962, Journal of medicinal and pharmaceutical chemistry.
[111] M. Pailer,et al. Pflanzliche Naturstoffe mit einer Nitrogruppe , 1958 .
[112] V. Danilovic,et al. [Chronic nephritis due to lead poisoning by digestive route (flour)]. , 1957, La Presse medicale.
[113] B. Stojimirovic,et al. Nephrites chroniques provoquées par l'intoxication au plomb par voie digestive (farine). , 1957 .
[114] M. Pailer,et al. Pflanzliche Naturstoffe mit einer Nitrogruppe II Die Konstitution der Aristolochiasäure-II , 1956 .
[115] M. Pailer,et al. Zur Konstitution der Aristolochiasäuren , 1955 .